Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Venadaparib hydrochloride (IDX-1197) is a potent and selective PARP inhibitor that exhibits significant anticancer properties. It is particularly effective in solid tumor research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | Venadaparib hydrochloride (IDX-1197) is a potent and selective PARP inhibitor that exhibits significant anticancer properties. It is particularly effective in solid tumor research. |
Targets&IC50 | PARP2:1 nM (IC50), PARP1:1.4 nM (IC50) |
In vitro | Venadaparib (example 143; 6-10 days) effectively inhibits the growth of MDA-MB-436 and Capan-1 pancreatic cancer cells, exhibiting IC 50 values of ≤5nM and 50nM[2], respectively. |
In vivo | In the germline BRCA1-mutated ovarian cancer patient-derived xenograft (PDX) model, oral administration of Venadaparib (IDX-1197) significantly inhibits PAR (>90%) in tumor tissues up to 24 hours post-dosing. Additionally, Venadaparib demonstrates dose-dependent, potent tumor growth inhibition, surpassing that of the Olaparib treatment group[1]. |
Synonyms | IDX-1197 hydrochloride |
Molecular Weight | 442.92 |
Formula | C23H24ClFN4O2 |
CAS No. | 1681020-60-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Venadaparib hydrochloride 1681020-60-9 IDX1197 Hydrochloride IDX-1197 hydrochloride IDX 1197 Hydrochloride Venadaparib Hydrochloride IDX-1197 Hydrochloride inhibitor inhibit